If we are good enough at selling ourselves we could be part of a cash rich pharma industry M&A upswing in 2013.
According to Bloomberg big pharma has over $70B in cash reserves that it is looking invest.
"Get ready for the return of the $10 billion-plus drug deal.
Pharmaceutical companies including Pfizer Inc. (PFE) and Bristol- Myers Squibb Co. (BMY) have spent the last several years digesting earlier acquisitions, refocusing their product development and setting aside cash in anticipation of expiring patents. Now, the expectation is they’re ready to start buying again. Led by Pfizer, in New York, and Whitehouse Station, New Jersey-based Merck & Co. (MRK), five of the largest U.S. drugmakers had more than $70 billion in cash, near cash and short-term investments at the end of the third quarter."
This is all on the table at the JPMorgan’s annual health-care conference so, if the cash is there and we have the technology, what is standing in the way of us getting some of this dough?
http://www.bloomberg.com/news/2013-01-07/pharma-deals-north-of-10-billion-seen-returning-in-2013.html
- Forums
- ASX - By Stock
- $1b deal here were come
If we are good enough at selling ourselves we could be part of a...
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online